Literature DB >> 29693246

Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.

Mary L McMaster1, Chongkui Sun2, Maria T Landi3, Sharon A Savage1, Melissa Rotunno4, Xiaohong R Yang3, Kristine Jones5, Aurélie Vogt5, Amy Hutchinson5, Bin Zhu5, Mingyi Wang5, Belynda Hicks5, Anand Thirunavukarason2, Douglas R Stewart1, Stella Koutros6, Alisa M Goldstein1, Stephen J Chanock7, Neil E Caporaso6, Margaret A Tucker8, Lynn R Goldin3, Yie Liu2.   

Abstract

In a previous whole exome sequencing of patients from 41 families with Hodgkin lymphoma, we identified two families with distinct heterozygous rare coding variants in POT1 (D224N and Y36H), both in a highly conserved region of the gene. POT1 D224N mutant did not bind to a single-stranded telomere oligonucleotide in vitro suggesting the mutation perturbs POT1's ability to bind to the telomeric G-rich overhang. Human HT1080 cells expressing POT1 D224N and lymphoblastoid cells carrying Y36H both showed increased telomere length and fragility in comparison to wild type cells. This strongly suggests that mutant POT1 causes chromosome instability and may play a role in lymphomagenesis in these families. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  zzm321990POT1zzm321990; Hodgkin lymphoma; genetic analysis; genomic instability; telomere

Mesh:

Substances:

Year:  2018        PMID: 29693246      PMCID: PMC5921926          DOI: 10.1111/bjh.15203

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma.

Authors:  Silva Saarinen; Mervi Aavikko; Kristiina Aittomäki; Virpi Launonen; Rainer Lehtonen; Kaarle Franssila; Heli J Lehtonen; Eevi Kaasinen; Peter Broderick; Jussi Tarkkanen; Barbara J Bain; Frédéric Bauduer; Ali Ünal; Anthony J Swerdlow; Rosie Cooke; Markus J Mäkinen; Richard Houlston; Pia Vahteristo; Lauri A Aaltonen
Journal:  Blood       Date:  2011-05-11       Impact factor: 22.113

Review 2.  Human leukocyte antigens and genetic susceptibility to lymphoma.

Authors:  K A McAulay; R F Jarrett
Journal:  Tissue Antigens       Date:  2015-08

Review 3.  The shelterin complex and hematopoiesis.

Authors:  Morgan Jones; Kamlesh Bisht; Sharon A Savage; Jayakrishnan Nandakumar; Catherine E Keegan; Ivan Maillard
Journal:  J Clin Invest       Date:  2016-05-02       Impact factor: 14.808

4.  Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells.

Authors:  Stephen J Salipante; Matthew E Mealiffe; Jeremy Wechsler; Maxwell M Krem; Yajuan Liu; Shinae Namkoong; Govind Bhagat; Tomas Kirchhoff; Kenneth Offit; Henry Lynch; Peter H Wiernik; Mikhail Roshal; Mary Lou McMaster; Margaret Tucker; Jonathan R Fromm; Lynn R Goldin; Marshall S Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

5.  Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene.

Authors:  Melissa Rotunno; Mary L McMaster; Joseph Boland; Sara Bass; Xijun Zhang; Laurie Burdett; Belynda Hicks; Sarangan Ravichandran; Brian T Luke; Meredith Yeager; Laura Fontaine; Paula L Hyland; Alisa M Goldstein; Stephen J Chanock; Neil E Caporaso; Margaret A Tucker; Lynn R Goldin
Journal:  Haematologica       Date:  2016-06-13       Impact factor: 9.941

Review 6.  Current insight on trends, causes, and mechanisms of Hodgkin's lymphoma.

Authors:  Neil E Caporaso; Lynn R Goldin; William F Anderson; Ola Landgren
Journal:  Cancer J       Date:  2009 Mar-Apr       Impact factor: 3.360

7.  Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing.

Authors:  Heikki Ristolainen; Outi Kilpivaara; Peter Kamper; Minna Taskinen; Silva Saarinen; Sirpa Leppä; Francesco d'Amore; Lauri A Aaltonen
Journal:  Br J Haematol       Date:  2015-02-25       Impact factor: 6.998

8.  Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.

Authors:  Jianxin Shi; Xiaohong R Yang; Bari Ballew; Melissa Rotunno; Donato Calista; Maria Concetta Fargnoli; Paola Ghiorzo; Brigitte Bressac-de Paillerets; Eduardo Nagore; Marie Francoise Avril; Neil E Caporaso; Mary L McMaster; Michael Cullen; Zhaoming Wang; Xijun Zhang; William Bruno; Lorenza Pastorino; Paola Queirolo; Jose Banuls-Roca; Zaida Garcia-Casado; Amaury Vaysse; Hamida Mohamdi; Yasser Riazalhosseini; Mario Foglio; Fanélie Jouenne; Xing Hua; Paula L Hyland; Jinhu Yin; Haritha Vallabhaneni; Weihang Chai; Paola Minghetti; Cristina Pellegrini; Sarangan Ravichandran; Alexander Eggermont; Mark Lathrop; Ketty Peris; Giovanna Bianchi Scarra; Giorgio Landi; Sharon A Savage; Joshua N Sampson; Ji He; Meredith Yeager; Lynn R Goldin; Florence Demenais; Stephen J Chanock; Margaret A Tucker; Alisa M Goldstein; Yie Liu; Maria Teresa Landi
Journal:  Nat Genet       Date:  2014-03-30       Impact factor: 38.330

9.  Mutations driving CLL and their evolution in progression and relapse.

Authors:  Dan A Landau; Eugen Tausch; Amaro N Taylor-Weiner; Chip Stewart; Johannes G Reiter; Jasmin Bahlo; Sandra Kluth; Ivana Bozic; Mike Lawrence; Sebastian Böttcher; Scott L Carter; Kristian Cibulskis; Daniel Mertens; Carrie L Sougnez; Mara Rosenberg; Julian M Hess; Jennifer Edelmann; Sabrina Kless; Michael Kneba; Matthias Ritgen; Anna Fink; Kirsten Fischer; Stacey Gabriel; Eric S Lander; Martin A Nowak; Hartmut Döhner; Michael Hallek; Donna Neuberg; Gad Getz; Stephan Stilgenbauer; Catherine J Wu
Journal:  Nature       Date:  2015-10-14       Impact factor: 49.962

10.  Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.

Authors:  P Gu; Y Wang; K K Bisht; L Wu; L Kukova; E M Smith; Y Xiao; S M Bailey; M Lei; J Nandakumar; S Chang
Journal:  Oncogene       Date:  2016-11-21       Impact factor: 9.867

View more
  14 in total

1.  A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations.

Authors:  Paula Martínez; Raúl Sánchez-Vázquez; Iole Ferrara-Romeo; Rosa Serrano; Juana M Flores; Maria A Blasco
Journal:  PLoS Genet       Date:  2022-06-21       Impact factor: 6.020

Review 2.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

3.  POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.

Authors:  M Potrony; J A Puig-Butille; M Ribera-Sola; V Iyer; C D Robles-Espinoza; P Aguilera; C Carrera; J Malvehy; C Badenas; M T Landi; D J Adams; S Puig
Journal:  Br J Dermatol       Date:  2019-02-27       Impact factor: 9.302

Review 4.  Long telomeres and cancer risk: the price of cellular immortality.

Authors:  Emily J McNally; Paz J Luncsford; Mary Armanios
Journal:  J Clin Invest       Date:  2019-08-05       Impact factor: 14.808

5.  Cancer-associated POT1 mutations lead to telomere elongation without induction of a DNA damage response.

Authors:  Won-Tae Kim; Kelsey Hennick; Joshua Johnson; Brendan Finnerty; Seunga Choo; Sarah B Short; Casey Drubin; Ryan Forster; Mary L McMaster; Dirk Hockemeyer
Journal:  EMBO J       Date:  2021-05-02       Impact factor: 14.012

6.  Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing.

Authors:  Aayushi Srivastava; Sara Giangiobbe; Abhishek Kumar; Nagarajan Paramasivam; Dagmara Dymerska; Wolfgang Behnisch; Mathias Witzens-Harig; Jan Lubinski; Kari Hemminki; Asta Försti; Obul Reddy Bandapalli
Journal:  Front Bioeng Biotechnol       Date:  2020-03-06

7.  The epigenetic regulator LSH maintains fork protection and genomic stability via MacroH2A deposition and RAD51 filament formation.

Authors:  Xiaoping Xu; Kai Ni; Yafeng He; Jianke Ren; Chongkui Sun; Yie Liu; Mirit I Aladjem; Sandra Burkett; Richard Finney; Xia Ding; Shyam K Sharan; Kathrin Muegge
Journal:  Nat Commun       Date:  2021-06-10       Impact factor: 14.919

Review 8.  The enigma of excessively long telomeres in cancer: lessons learned from rare human POT1 variants.

Authors:  Yi Gong; Amanda J Stock; Yie Liu
Journal:  Curr Opin Genet Dev       Date:  2020-03-08       Impact factor: 4.665

9.  Telomere-related Markers for Cancer.

Authors:  Xiaotian Yuan; Mingkai Dai; Dawei Xu
Journal:  Curr Top Med Chem       Date:  2020       Impact factor: 3.295

10.  Establishment and Characterization of a Reliable Xenograft Model of Hodgkin Lymphoma Suitable for the Study of Tumor Origin and the Design of New Therapies.

Authors:  Radhia M'kacher; Monika Frenzel; Mustafa Al Jawhari; Steffen Junker; Corina Cuceu; Luc Morat; Anne-Laure Bauchet; Lev Stimmer; Aude Lenain; Nathalie Dechamps; William M Hempel; Geraldine Pottier; Leonhard Heidingsfelder; Eric Laplagne; Claire Borie; Noufissa Oudrhiri; Dima Jouni; Annelise Bennaceur-Griscelli; Bruno Colicchio; Alain Dieterlen; Theodore Girinsky; Raphael Boisgard; Jean Bourhis; Jacques Bosq; Thomas Mehrling; Eric Jeandidier; Patrice Carde
Journal:  Cancers (Basel)       Date:  2018-10-31       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.